Factors influencing a specific histologic diagnosis of non-small cell lung cancer.
Jeffrey Sulpher(BC Cancer Agency), Paul Wheatley‐Price(University of Ottawa), Geng Liu, Scott Owen(McGill University Health Centre), Frances A. Shepherd(University Health Network), Christina M. Canil(University of Ottawa), Kimberly Tobros(University Health Network), H. Hon, Elham Sabri(Ottawa Hospital)
Cited by 2
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k